Fibrogenesis Imperfecta Ossium and Response to Human Growth Hormone: A Potential Therapy | Zendy

Sanjay Kumar Bhadada | Zendy; Vandana Dhiman | Zendy; Soham Mukherjee | Zendy; Sameer Aggarwal | Zendy; Amanjit Bal | Zendy; Suja Sukumar | Zendy; Ashwani Sood | Zendy; Dinesh C Sharma | Zendy; Niranjan Khandelwal | Zendy; Anil Bhansali | Zendy; Wim Van Hul | Zendy; Sudhaker D. Rao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fibrogenesis Imperfecta Ossium and Response to Human Growth Hormone: A Potential Therapy

Author(s) -

Sanjay Kumar Bhadada,

Vandana Dhiman,

Soham Mukherjee,

Sameer Aggarwal,

Amanjit Bal,

Suja Sukumar,

Ashwani Sood,

Dinesh C Sharma,

Niranjan Khandelwal,

Anil Bhansali,

Wim Van Hul,

Sudhaker D. Rao

Publication year - 2017

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-3055

Subject(s) - medicine , osteogenesis imperfecta , osteomalacia , bone remodeling , bone disease , parathyroid hormone , endocrinology , biopsy , bone density , pathology , osteoporosis , calcium

Fibrogenesis imperfecta ossium (FIO) is a rare bone disease manifested by generalized bone pain, fragility fractures, progressive disability, and extensive mineralization defect seen in bone biopsy specimens. The pathogenesis of the disease is unknown and currently there is no effective treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research